Ownership history in CITIGROUP INC · 2 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in APREA THERAPEUTICS INC (APRE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 5 | -19 | -79.2% | 0.00% | $7 | $1.48 |
| 2024 Q4 | INITIATED | 24 | — | — | 0.00% | $79 | $3.29 |
As of 2025 Q4 — sorted by position size